• Home
  • Supplier
  • Distributor
  • Career
  • Contact
  • CSR
NSE Logo
Infinium Pharmachem Limited Logo
  • About Us
    • Overview
    • Board of Directors
    • Vision & Mission
    • Our Commitment
    • Milestones
    • Corporate Management
    • Manufacturing Facility
    • Reserach & Development Facility
    • Our Customers
    • Infinium Advantages
  • Products
    • A To Z Products
    • Iodine Derivatives
    • APIs
  • Industries
    • Overview
    • Pharmaceuticals & Biotech
    • Specialty & Performance Chemicals
    • Dairy, Food & Neutraceutical
    • Animal Care
    • Agrochemical
    • Paints, Coating, Dyes & Textile
    • Ink, Paper & Printing
    • Rubber & Nylon Tyre
    • Oil & Gas
    • Cosmetics, Sanitation, Personal Care & Industrial Care
    • Gold & Imitation Jewelry
    • Medical
    • Radiography
    • Nuclear Science
    • Gemological
    • Renewable Energy (Solar,Biomass)
    • Electrical
    • Electronics
    • Mechanical
    • Aquarium
    • Photography
    • Tobacco
    • Fireworks
  • CRAMS
  • Quality
    • Overview
    • Good Manufacturing Practices (GMP)
    • Quality Services
    • Certifications
    • GHS
    • Labeling & SDS
    • Packaging
  • Support
    • Logistics
  • Investors
    • Shareholder’s Information
      • Shareholding Pattern
      • Intimation to Stock Exchanges
    • Financial Information
      • Half Yearly Financial Results
      • Audited Financial Result
      • Annual Report
      • Notice of 21’st AGM
      • Notice of 19’th AGM
      • Investor Contact
    • Corporate Governance
      • Board of Directors
      • Composition of the Committees
    • Material Creditors
      • List Of Material Creditors
    • IPO
      • DRHP
      • Addendum
      • Disclosure of Material Contracts and Documents
      • Prospectus
    • Subsidiary Company Financials
      • Shanghai Tajilin Industrial Co. Ltd.
      • Infinium Green Energy Pvt. Ltd.
    • Investor Update
      • Financial Year 2024
  • EHS
  • NEWS & EVENTS
    • News
    • Events

Half Yearly Financial Results

  • Home
  • Half Yearly Financial Results

Half Yearly Financial Results

Annual Reports

HY1 FY22-23

Audited Consolidated Financial Results for the Half year ended 30th September, 2022

Audited Standalone Financial Results for the Half year ended 30th September, 2022


FY22-23

Audited Financial Results for the year ended 31st March, 2023


HY1 FY23-24

Unaudited Financial Results with limited review report for Half Year ended on 30th September, 2023


H1 FY 24-25

Unaudited Financial Results with limited review report for Half Year ended on 30th September, 2024


H1 FY 25-26

Unaudited Standalone Financial Results for the Half Year ended on 30th September, 2025

Unaudited Consolidated Financial Results for the Half Year ended on 30th September, 2025

Investors Presentation On Unaudited Consolidated Financial Results for the Half Year ended on 30th September, 2025


Corporate Office

  • INFINIUM PHARMACHEM LIMITED
    Suite #205, "SIGMA PRIME", Second Floor,
    Nr. Sardar Patel Statue, V.U. Nagar GIDC Road,
    Vallabh Vidyanagar - 388120 Gujarat, INDIA.

Contact Us

  • +91-2692-238849 / 238850
  • info@infiniumpharmachem.com
  • export@infiniumpharmachem.com

Downloads

Corporate Presentation Corporate Brochure
Copyright © 2026 Infinium Pharmachem Limited - All Rights Reserved
Designed by GID and Promoted by MID